Back to Search
Start Over
Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis.
- Source :
-
The European respiratory journal [Eur Respir J] 2022 May 05; Vol. 59 (5). Date of Electronic Publication: 2022 May 05 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Competing Interests: Conflict of interest: T.C. Lee reports grants or contracts from Fonds de Recherche Quebec – Sante, Canadian Institutes of Health Research, and McGill Interdisciplinary Institute Infection and Immunity, outside the submitted work. S. Belga reports grants or contracts from Vancouver Coastal Health Research Institute and Transplant Research Foundation of BC, outside the submitted work. E.G. McDonald reports that the study drug for the CONTAIN trial, which is one study in this meta-analysis, was donated to our team by COVIS pharmaceuticals. N. Ezer reports grants or contracts from Fonds de Recherche du Québec en Santé, Rossy Cancer Network, Canadian Institute of Health Research, and MEDTEQ, outside the submitted work; consulting fees were received from GlaxoSmithKline and AstraZeneca, outside the submitted work; receipt of equipment, materials, drugs, medical writing, gifts or other services from COVIS Pharma (study drug donation for CONTAIN trial; unrestricted). The remaining authors have nothing to disclose.
Details
- Language :
- English
- ISSN :
- 1399-3003
- Volume :
- 59
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The European respiratory journal
- Publication Type :
- Report
- Accession number :
- 35144994
- Full Text :
- https://doi.org/10.1183/13993003.02921-2021